M&A Deal Summary

Morgan Stanley Private Equity Asia Acquires Coinage International

On January 1, 2016, private equity firm Morgan Stanley Private Equity Asia acquired education company Coinage International

Acquisition Highlights
  • This is Morgan Stanley Private Equity Asia’s 2nd transaction in the Education sector.
  • This is Morgan Stanley Private Equity Asia’s 15th transaction in China.

M&A Deal Summary
Date 2016-01-01
Target Coinage International
Sector Education
Buyer(s) Morgan Stanley Private Equity Asia
Deal Type Buyout (LBO, MBO, MBI)

Target

Coinage International

Beijing, China
Coinage International is a provider of financial education and training services. Coinage International was founded in 2004 and is based in Beijing, China.

Search 202,463 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Morgan Stanley Private Equity Asia

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
Size Large
Type Sector Agnostic
DESCRIPTION

Morgan Stanley Private Equity Asia is a direct investment affiliate of Morgan Stanley that looks to acquire minority investments in companies with substantial business operations throughout Asia. The Unit has a preference for fast-growing businesses with strong brands and sustainable competitive advantages. In addition to minority deals, the Firm will also consider select control situations. Morgan Stanley Private Equity Asia was formed in 1993 and is headquartered in Hong Kong.

DEAL STATS #
Overall 21 of 35
Sector (Education) 2 of 4
Type (Buyout (LBO, MBO, MBI)) 5 of 6
Country (China) 15 of 18
Year (2016) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-01 Yongye International

Beijing, China

Yongye International is a crop nutrient company in China. Yongye's product is composed of high quality fulvic acid base and various nutrients that can supplement the absorption of fertilizer and minerals, improve crop yield, reduce chemical fertilizer/pesticide residue, and enhance natural resistance to disease. Yongye International is based in Beijing, China.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-18 Buchang Pharmaceutical

Heze, China

Buchang Pharmaceutical is principally engaged in R&D, production and sales of traditional Chinese medicines (”TCM”) in China with a focus on the cardiovascular diseases therapeutic area. Buchang produces branded, patented, and mostly prescription-only TCM in different delivery formats. Buchang’s products can found in 15,000 hospitals and 150,000 drug stores across China and have been used by more than 50 million patients. Buchang Pharmaceutical was founded in 1993 and is based in Heze, China.

Sell -
Mergr

Product

Company

Legal